Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
EMIT Imaging logo — Industry-leading CFT instrument & services provider: 3D imag...

EMIT Imaging

Industry-leading CFT instrument & services provider: 3D imaging tool to monitor drug distribution and protein expression

Founded 2018 United States Baltimore, United States 21 employees Debt Financing Total: $6.40M Biotechnology

General Information

Company Name EMIT Imaging
Founded Year 2018
Location United States Baltimore, United States +1
Employees 21
Industries Biotechnology
Funding Stage Debt Financing
Social

Get notified when EMIT Imaging moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About EMIT Imaging

EMIT Imaging is a biotechnology startup founded in 2018, headquartered in the United States. Specializing in Cryo-Fluorescence Tomography (CFT), they provide a novel, 3D imaging tool for monitoring drug distribution and protein expression in whole animals and large tissue samples. Their platform, XerraTM, offers high-resolution and high-sensitivity preclinical imaging, enabling advancements in biological and drug research. EMIT Imaging's services and instrumentation aim to overcome the limitations of standard 2D in vivo fluorescence imaging techniques. They enable better visualization of whole-body drug distribution, candidate drug screening, therapeutic protein expression, multiplexed co-localization of drugs with targets, and on and off-target tissue identification. The company recently secured a $525.00K debt financing investment on 15 September 2023. This funding is expected to drive further development and expansion of their innovative CFT technology and imaging platform. With a strong focus on addressing critical needs in drug research and biological discoveries, EMIT Imaging holds the potential to make significant contributions to the biotechnology industry, offering valuable solutions and services to researchers, pharmaceutical companies, and other stakeholders.

Taxonomy: Cryo-Fluorescence Tomography, 3D imaging, Drug distribution, Protein expression, Preclinical imaging, Biology research, Drug research, Instrumentation, Imaging platform, Therapeutic protein, Drug delivery, Multiplexed co-localization, Biological discoveries, In vivo fluorescence imaging, Tissue samples

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing •••••• - 15 Sep 2023
Venture Round •••••• - 11 Apr 2023

EMIT Imaging Alternatives & Competitors

EMIT Imaging vs
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. United States

Intraoperative imaging to revolutionize cancer surgery

Series Unknown
5 employees
Analytics, Biotechnology
EMIT Imaging vs
IVIM Technology
IVIM Technology Korea South

Global No.1 solution provider of IntraVital Microscopy

Series C
29 employees
Biopharma, Biotechnology
EMIT Imaging vs
Xeragenx
Xeragenx United States

A biotech company committed to improving global health by “Reinventing B12”

1 employees
Biotechnology

FAQ About EMIT Imaging

Industry-leading CFT instrument & services provider: 3D imaging tool to monitor drug distribution and protein expression
EMIT Imaging was founded in 2018.
EMIT Imaging is headquartered in Baltimore, United States.
EMIT Imaging operates in the following industries: Biotechnology.
EMIT Imaging has approximately 21 employees.
EMIT Imaging has completed 2 funding rounds, raising a total of $6.40M. The latest funding stage is Debt Financing.
Top alternatives and competitors to EMIT Imaging include Avelas Biosciences, Inc., IVIM Technology, Xeragenx, Voxcan, NanoImaging Services. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EMIT Imaging and Avelas Biosciences, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors EMIT Imaging and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy